InvestorBrandNetwork (IBN) Content Platform

Sky Harbour Group (NYSE American: SKYH, SKYH WS), an aviation infrastructure company building the first nationwide network of home-basing solutions for business aircraft, has executed an agreement with the town of Addison, Texas; the agreement almost doubles Sky Harbour’s footprint at Dallas’s Addison Airport (“ADS”). According to the agreement, the amended lease means that SKYH’s rentable square footage at ADS will expand to approximately 195,000. The company noted that it has open, operating campuses at Houston’s Sugar Land Regional Airport and Nashville International Airport; plans are in place to open campuses at the Miami Opa-Locka Executive Airport, Denver Centennial Airport and Phoenix Deer Valley Airport.

“Dallas is among the largest business jet hubs in the country and one of Sky Harbour’s strongest markets,” said Sky Harbour Group CEO and chair Tal Keinan in the press release. “Addison is positioned in a prime location within the Dallas metro center and enjoys outstanding airport management. We believe the expanded Sky Harbour campus will strengthen Addison’s position as the airport of choice for many of Dallas’s top private and corporate flight departments.”

To view the full press release, visit https://ibn.fm/LBotN

About Sky Harbour Group Corporation

Sky Harbour Group is an aviation infrastructure company developing the first nationwide network of home-basing solutions for business aircraft. The company develops, leases and manages general aviation hangars across the United States. Sky Harbour’s home basing solution aims to provide private and corporate customers with the best physical infrastructure in business aviation, coupled with dedicated service tailored to based aircraft, offering the shortest time to wheels-up in business aviation. To learn more about the company, visit www.SkyHarbour.group

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Brain Scientific (OTCQB: BRSF), a Florida-based applied science technology company, has signed a distribution agreement with Hansraj Nayyar Medical–India Pvt. Ltd., a nearly century-old, multigenerational company with a wide network of hospitals located in India. The partnership will expand Brain Scientific’s footprint as it opens up a significant larger market and creates an invaluable relationship with a well-established distributor in India. Officials from Hansraj Nayyar, a century-old company, noted their excitement about the partnership, stating that “we know a good medical device when we see it — one that meets the needs of our large customer base. Brain Scientific’s integrated system is precisely what our medical communities have been asking us for.” The collaboration will enable Brain Scientific to expand its sales and distribution network and strengthen its position as a global leader in the medical wearables space. “Partnering with Hansraj Nayyar, with coverage of the Indian market, greatly increases our ability to reach global customers who are looking for innovative solutions to their neurological testing challenges,” said Brain Scientific CEO Hassan Kotob in the press release. “We continue to see increased orders and accelerated demand for our neurology devices as the marketplace realizes the efficiency of our products.”

To view the full press release, visit https://ibn.fm/E2Ko3

About Brain Scientific Inc.

Brain Scientific is an applied sciences technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of medical and OEM devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap(TM) and NeuroEEG(TM) are smart neurological diagnostic devices that simplify administration, shorten scan time and cut costs. The Piezo Motion product line consists of ultraefficient compact precision motors that will drive the next generation of OEM devices. To learn more about the company, visit www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Predictive Oncology (NASDAQ: POAI) CEO Raymond Vennare has issued a letter to shareholders, providing an overview of the company and a look at the significant progress the company has made in respect to validating its commercial platform and publishing its proof of concept. In the letter, Vennare noted that Predictive Oncology is now in a position where it can focus all of its energy and resources on conducting transactions with biopharmaceutical partners and drive adoption of its proprietary PEDAL(TM) platform. Vennare called PEDAL “the drug discovery engine that will ultimately drive the future growth of the company” and noted that it is the synergy and interoperability of PEDAL in concert with the company’s CLIA laboratory, biorepository of tumor samples and GMP facility that will transform our business. He also recognized the company’s team of world-class scientists and the significant and sustained investment in this company that has brought POAI to its present state. The shareholder letter summarized the company’s key achievements, including a concerted effort to rebrand and reposition Predictive Oncology as “a science-driven company utilizing proprietary artificial intelligence (‘AI’) to accelerate drug discovery and enable drug development.” The letter also provided a detailed description of the PEDAL platform, outlined market conditions, included a financial overview and explained upcoming plans. “The senior management and board of directors of Predictive Oncology have been entirely focused on addressing the most critical issues facing the company over the past few months: compliance with NASDAQ’s listing requirements, stabilizing the company’s equity, restoring investor confidence, negotiating agreements and executing new customer contracts,” stated Predictive Oncology CEO Raymond Vennare in the letter. “Our emphasis has been, and will continue to be, on closing deals, driving adoption of the PEDAL platform and satisfying existing contracts. Our proposals, negotiations and engagements range from fee-for-service, upfront compensation, short-term milestone payments and long-term royalty fees. Opportunities currently in the pipeline include national and international biopharmaceutical, biologics, therapeutics and cancer research organizations, as well as government agencies. We will continue to pursue every opportunity to reach and maintain NASDAQ compliance, expedite sales efforts, close on contracts and improve shareholder value.”

To view the full press release, visit https://ibn.fm/E9bXT

About Predictive Oncology Inc.

Predictive Oncology, a science-driven company on the leading edge of oncology drug discovery, offers an unrivaled suite of solutions for the biopharma industry. Through the integration of scientific rigor and machine learning, the company has developed the ability to advance molecules into medicine more confidently by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the world’s largest privately held biobank of more than 150,000 tumor samples. Predictive Oncology’s solutions additionally include tumor models, biologics development, formulation design, a GMP facility, a CLIA laboratory and substantial scientific domain expertise. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, has named an interim chief financial officer. According to the announcement, Mary Lay Hoitt, CPA, will serve in the position that was vacated after J. Drew Byelick resigned. Hoitt comes to the position with more than 25 years serving at both public and private firms in chief financial officer and vice president roles. She has experience with companies ranging from early-stage startups to global companies with annual revenues of more than $300 million. Hoitt has been involved with restructuring and turning around numerous distressed entities, including three mergers and one management buyout within the United States and eight acquisitions and three divestures for European and South American corporations. “Mary is an experienced, highly respected leader with a strategic financial mindset to support RYVYL in our process of restating previously issued financial statements and filing our upcoming 2022 year-end annual report,” said RYVYL chair Ben Errez in the press release. “We welcome her to the position and are pleased to have someone of her caliber and financial skill set serve as our Interim CFO. I’m confident that Mary’s demonstrated success in leading finance departments of companies in complex, highly competitive industries, will help us deliver for our shareholders. On behalf of our board and management team, I would also like to thank Drew for his service and contributions to RYVYL.”

To view the full press release, visit https://ibn.fm/HRy27

About RYVYL

RYVYL was born from a passion for empowering a new way to conduct business-to-business, consumer-to-business and peer-to-peer payment transactions around the globe. By leveraging unique blockchain security and USD-pegged stablecoin technology with near real-time attestation, RYVYL is reinventing the future of financial transactions using its coyni(R) stablecoin platform as a transactional foundation. Since its founding as GreenBox POS in 2017, RYVYL has developed applications enabling an end-to-end suite of turnkey financial products with enhanced security and data privacy, world-class identity theft protection and rapid speed to settlement. As a result, the platform can log immense volumes of immutable transactional records at the speed of the internet for first-tier partners, merchants and consumers around the globe. For more information about the company, please visit www.GreenBoxPOS.com.

NOTE TO INVESTORS: The latest news and updates relating to RVYL are available in the company’s newsroom at https://ibn.fm/RVYL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles, announced that manufacturing has started on 18 zero-emission street sweepers that feature US Hybrid’s electric and hybrid electric propulsion kits. US Hybrid is an Ideanomics’ subsidiary. According to the announcement, the street sweepers are being made by California-based Global Environmental Products (“GEP”), which will deliver the sweepers to the California Department of Transportation (Caltrans) in the coming weeks. The company noted that GEP is also manufacturing additional zero-emission sweepers for other customers. US Hybrid and GEP formed a partnership in 2022 when the two companies began collaborating to develop 62 zero-emission street sweepers. Currently, GEP is producing zero-emission sweepers for New York City, the city of South San Francisco, Washington, DC, and Helena, Montana. US Hybrid manufactures its electric and hybrid electric propulsion kits in Torrance, California, and GEP manufactures all its sweepers in California. “Together, US Hybrid and GEP are taking action to help cities transition some of the biggest, hardest to decarbonize specialty vehicles — like street sweepers — to zero emission,” said Ideanomics chief commercial officer Macy Neshati in the press release. “We are doing this work right here in California, supporting a new generation of green jobs and developing cutting-edge zero-emission technology.”

To view the full press release, visit https://ibn.fm/fXDZh

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: to accelerate the commercial adoption of electric vehicles. By bringing together vehicles, charging and financing solutions under one roof, the company has become the one-stop partner needed to simplify the transition to and operation of any EV fleet.  For more information about the company, please visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today reported financial results for the fourth quarter and full year 2022 and provided a corporate and commercial update. “During the fourth quarter, we continued to see substantial improvements in our financial results driven by our pivot to a business-to-business (‘B2B’) business model, including robust revenue growth, an increase in gross margin, lower operating expenses and net loss, and reduced cash usage,” said Erez Raphael, chief executive officer of Dario. “Notably, operating loss in the fourth quarter declined by 58% to $9 million compared to $21.7 million in the fourth quarter of 2021 and non-GAAP operating loss in the fourth quarter declined by 60% to $6 million compared to $15 million in the fourth quarter of 2021. These metrics demonstrate the significant revenue growth and operating expense efficiency that has resulted from the strategic transition to B2B integrated multi-condition platform, which continues to gain traction in the market.”

To view the full press release, visit https://ibn.fm/ivgQn

About DarioHealth Corp.

DarioHealth is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market – covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Dario’s next-generation, AI-powered, digital therapeutic platform supports more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software, and coaching to help individuals improve health and sustain meaningful outcomes. Dario’s unique user-centric approach to product design and engagement creates an unparalleled experience that is highly rated by users and delivers sustainable results. The company’s cross-functional team operates at the intersection of life sciences, behavioral science and software technology and utilizes a performance-based approach to improve its users’ health. On the path to better health, Dario makes the right thing to do the easy thing to do. To learn more about DarioHealth and its digital health solutions or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO  

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

FE Battery Metals (CSE: FE) (OTCQB: FEMFD), a publicly traded Canadian mineral exploration company, has announced drilling results from Drill Hole LC23-42 at its Augustus Lithium project. The results are from the 2023 exploratory drill program and indicate that the drill hole intersected two pegmatites with widths of 16 meters and 4 meters, respectively, showing varying lithium grades from 164 to 250 meters drilled depth. Other highlights of the report show that the upper pegmatite is 16 meters wide with average 0.41% Li2O or 1,911 parts per million (“ppm”) lithium (“Li”) at 164 m drilled depth, including a two-meter-wide zone grading 1.17% Li2O at 167 m depth and the lower pegmatite is 4 meters wide with average 0.13% Li2O or 588 ppm Li at 235 m drilled depth. In addition, the drilling shows anomalous values of other rare metals in these pegmatite zones. According to the announcement, FE Battery Metals has conducted 50 drill holes to date at Augustus, with a cumulative core drilling of more than 9,500 meters have been completed.

To view the full press release, visit https://ibn.fm/eYe8P

About FE Battery Metals Corp.

FE Battery Metals is focused on identifying, exploring and advancing early-stage lithium pegmatite projects in Canada. The company’s primary efforts have been on exploration projects located in Quebec, with its flagship property being the Augustus Lithium Property. Augustus is located in the immediate vicinity of Val d’Or Quebec, where several historical prospects and a previously active lithium mine is located within a 10 km radius from the property. North American Lithium mine (“NAL”) and the Authier Project are two notable projects in the area that highlight the potential of the Augustus Lithium Property. For more information about the company, please visit www.FirstEnergyMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to FEMFF are available in the company’s newsroom at https://ibn.fm/FEMFF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

VistaGen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, has announced key updates regarding its phase 1 clinical trial of itruvone (“PH10”). The company reported that the last participant in the trial has completed the study protocol. PH10 is VistaGen’s investigational pherine nasal spray for the treatment of major depressive disorder (“MDD”). According to the announcement, the study was designed to confirm the favorable safety profile of itruvone, which had been established in three previous clinical studies conducted in Mexico. The company expects to see top line results from the study in Q2 2023. “With the treatment protocol for our final enrolled participant complete, we look forward to reviewing the data and advancing phase 2B development plans for itruvone as an innovative treatment for major depressive disorder,” said VistaGen Therapeutics CEO Shawn Singh in the press release. “Major depressive disorder continues to disrupt the lives of millions of individuals, and there is clear need for safer, more effective treatments, especially treatments with potential for rapid-onset and sustained benefits without causing sexual side effects or weight gain. We anticipate this U.S. phase 1 trial will build on itruvone’s exceptional safety and tolerability profile as demonstrated in all prior clinical studies to date.”

To view the full press release, visit https://ibn.fm/Rtf6K

About VistaGen Therapeutics Inc.

Vistagen is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting, and with fewer side effects and safety concerns than those that are currently available for treatment of anxiety and depression. Several of Vistagen’s product candidates belong to a new class of drugs known as pherines, which are designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact key neural circuits without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression. For more information about the company, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Data443 Risk Mitigation (OTC: ATDS) is focused on its commitment to supporting business-critical data in flight and at rest, while meeting the growing need for data discovery, governance and protection services. Cyberattacks are considered the fastest-growing crime in today’s world, where more and more business and personal lives are online. In fact, the global cybersecurity market is expected to snowball with a projected CAGR of 12.8% from 2022 to 2030, generating US$657.02 billion by the end of that period. “As more and more large corporations invest in cybersecurity infrastructure, criminals are increasingly targeting small and medium-sized companies, which tend to have less resilient cyber protection,” reads a recent article. “In a heated environment like this, where criminals are quick to adapt and take advantage of exposed vulnerabilities, Data443 Risk Mitigation has emerged as a critical player within the cybersecurity space with an extensive product suite and comprehensive toolset designed to help companies securely manage data on-premises, in the cloud and in hybrid environments. The company helps customers prioritize risk, detect security gaps, and implement adequate data protection and privacy management procedures by providing a comprehensive range of products and services, including data archiving, file sharing, ransomware recovery and access control to sensitive content management and global privacy management.”

To view the full article, visit https://ibn.fm/x5is1

About Data443 Risk Mitigation Inc.

Data443 Risk Mitigation provides software and services to enable secure data across devices and databases, at rest and in flight/in transit, locally, on a network, or in the cloud. The company is All Things Data Security(TM). With over 10,000 customers in over 100 countries, Data443 provides a modern approach to data governance and security by identifying and protecting all sensitive data regardless of location, platform or format. Its framework helps customers prioritize risk, identify security gaps, and implement effective data protection and privacy management strategies. For more information, please visit www.Data443.com.

NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, today announced the launch of its new 4G GPS SmartSole in the U.K. The rollout was completed through MetAlert’s distribution partner Possum Ltd. “We are excited to be launching the next generation of 4G SmartSole in the U.K. with our distribution partner of many years, Possum,” said MetAlert Director Andrew Duncan. “The U.K. is very strategic with its advance use of technology, like telecare and remote monitoring devices to bring efficiencies and better patient care to a stretched health care system. Possum is a market leader in this area, and we have great confidence in their ability to support our products and continue to build brand awareness and acceptance of the product amongst health care authorities and private health care organizations.”

To view the full press release, visit https://ibn.fm/lDuku

About MetAlert Inc.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, selling and licensing products, services and intellectual property in the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring sectors. With over 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with movement, cognitive and spatial awareness disorders. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software and connectivity solutions, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products, enterprise and government agency applications. The company’s solutions utilize the latest in miniaturized, low power consumption GPS, cellular, RF, NFC, and BLE technologies, enabling caregivers to track and monitor patients in real time. MetAlert is known for its game-changing and award-winning patented GPS SmartSole(R) — think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in over 40 countries and is a U.S. military government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers. For more information, visit the company’s website at www.MetAlert.com.

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

BlockQuarry (OTC: BLQC), a Texas-based company with commercial-stage operations in the energy and infrastructure industry focusing on cryptocurrency hosting and self-mining with a focus on Bitcoin, is reporting on its operational and growth strategy for the second quarter 2023. The information was included in shareholder information provided by BlockQuarry management. According to the report, in the next few months the company plans to focus on the following strategic items: completing the company’s 2022 annual audit; continuing to reduce liabilities and debt on the balance sheet; having an effective S1 registration statement; powering the company’s self-mining equipment online; and extending the power and land contracts at the company’s flagship Gaffney, South Carolina, site. “There are some tough tasks ahead for the company to complete operationally, but we view it as good practice in our efforts to uplist to the NASDAQ,” said BlockQuarry president and chair Alonzo Pierce in the press release. “The company has delivered some historical moments in company history the last few months, and we want to continue that momentum leading into the second quarter. Our focus continues to be laying out the foundational groundwork to build upon in order to deliver as much value as possible for all. . . . We have had many internal discussions about BlockQuarry’s growth strategy and vision for the future of the company. The main focus for this next quarter is continuing to expand our network and portfolio of clean energy and land contracts across the United States, as well as continuing our efforts to clean up our balance sheet.”

To view the full press release, visit https://ibn.fm/zbfDu

About BlockQuarry Corp.

BlockQuarry Corp. is an energy and infrastructure company focused on cryptocurrency hosting and self-mining operations, with leased properties located within the southeast United States. BlockQuarry Corp. also maintains a fleet of digital/cryptocurrency mining equipment and infrastructure. For more information about the company, visit www.BlockQuarry.io.

NOTE TO INVESTORS: The latest news and updates relating to BLQC are available in the company’s newsroom at http://ibn.fm/BLQC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

QSAM Biosciences (OTCQB: QSAM) is developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam(R)), for the treatment of bone cancer and related diseases and conditions. The company today announced clearance, by the U.S. Food & Drug Administration (“FDA”), of its amended clinical trial protocol increasing the maximum age of participants to 75 years old from the prior age limitation of 65. This amendment significantly expands the population of potential participants in QSAM’s phase 1 study evaluating CycloSam in the treatment of bone cancer. “We thank the FDA for clearing our amended clinical trial protocol, which should allow us to accept a greater percentage of the participants screened for enrollment, and, as a result, move the study ahead more quickly and efficiently,” said Douglas Baum, CEO of QSAM. “Our mission at QSAM is making sure the broadest possible population fighting this deadly disease may one day be able to benefit from CycloSam.”

To view the full press release, visit https://ibn.fm/11DUJ

About QSAM Biosciences Inc.

QSAM Biosciences is developing next-generation nuclear medicines for the treatment of cancer and related diseases. QSAM’s initial technology, CycloSam(R) (Samarium-153 DOTMP), is a clinical-stage bone-targeting radiopharmaceutical developed by IsoTherapeutics Group LLC, pioneers in the nuclear medicine space who also developed the FDA-approved Quadramet(R) (Samarium-153 EDTMP) radiopharmaceutical product. The QSAM team has designed the CycloSam product with the goal of overcoming the limitations of the Quadramet(R) (Samarium-153 EDTMP) product’s FDA-approved indications. QSAM is led by an experienced executive team and board of directors that have completed numerous FDA approvals and multiple successful biotech exits. For more information, visit the company’s website at https://QSAMBio.com.

NOTE TO INVESTORS: The latest news and updates relating to QSAM are available in the company’s newsroom at http://ibn.fm/QSAM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vivos Therapeutics (NASDAQ: VVOS) is a medical device and technology company that delivers training and a full line of highly effective proprietary oral appliances for the treatment of breathing-related sleep disorders in adults. The company today announced that its chairman and CEO Kirk Huntsman and CFO Brad Amman will participate at the 35th Annual ROTH Conference. The event is being held virtually and in-person in Dana Point, California, from March 12-14, 2023. Huntsman and Amman will conduct one-to-one meetings with investors during the conference and participate in a fireside chat with ROTH senior research analyst Scott Henry, which is slated to begin at 1:30 p.m. PT on Tuesday, March 14. Interested parties can access the live webcast of the fireside chat at a link that will be available on Vivos’ Investor Relations page.

To view the full press release, visit https://ibn.fm/RovOl

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing-related sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) and snoring in adults. The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA. It has proven effective in approximately 31,000 patients treated worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and/or palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentists training and other value-added services in connection with using The Vivos Method. For more information, visit www.Vivos.com.

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has announced its participation in two March conferences: the 35th annual Roth Conference and the BIO-Europe Spring Conference. The Roth Conference is scheduled for March 12–14, 2023, in Dana Point, California. During this conference, the company will showcase its innovate gene therapy programs in oncology and diabetes as Genprex CFO Ryan Confer meets one-on-one with other conference attendees. In addition, several members of the Genprex management team are slated to attend the BIO-Europe Spring event, which is scheduled for March 20–22, and will be held in Switzerland. Company representatives will also be available to meet with other conference attendees at this event. “We are pleased to have members of our senior leadership team participate in these upcoming conferences as they offer an excellent opportunity to highlight the significant potential for our novel gene therapies to address unmet medical needs in oncology and diabetes,” said Genprex CEO Rodney Varner in the press release. “We look forward to providing an overview and update on our clinical development programs, including our phase 1 dose escalation portion of the Acclaim-1 phase 1/2 clinical trial of REQORSA(R) (quaratusugene ozeplasmid) in combination with Tagrisso(R) (osimertinib) to treat late-stage non-small cell lung cancer and our recent groundbreaking data from a nonhuman primate study evaluating our innovative gene therapy to treat type 1 diabetes presented at a global medical meeting.”

To view the full press release, visit https://ibn.fm/jbna2

About Genprex Inc. 

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, which currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, nonviral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic, gene-therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is then administered intravenously, where it is then taken up by tumor cells that express proteins that are deficient in the body. The company’s lead product candidate, REQORSA (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for non-small cell lung cancer (“NSCLC”) and small cell lung cancer. Both NSCLC clinical programs receiving a fast track designation from the Food and Drug Administration. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an endoscope and an adeno-associated virus (“AAV”) vector to deliver Pdx1 (“Pdx1”) and MafA (“MafA”) genes to the pancreas. In models of type 1 diabetes, GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system. In a similar approach, GPX-003 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles, and its subsidiary Energica Motor Company are providing an update regarding the Energica facility located in Modena, Italy. According to the announcement, Energica has entered the third phase of its expansion plans, which calls for adding a 12,370-square-foot facility to the location; the new structure will be dedicated to Energica Inside, research and development, and prototype development and testing. Energica is the maker of the world’s leading high-performance electric motorcycle. The update also noted that the company is making progress on plans to expand its manufacturing and assembly facilities, including a target for automation designed to enable the electric motorcycle manufacturer to deliver on increased market demand. “From the beginning, Energica has been a crucial leader in Italy regarding EV recruitment and innovation,” says Energica Motor Company CEO Livia Cevolini in the press release. “Our reputation and know-how enables Energica to attract talented people from around the world who often choose to stay and build their career with us. We look forward to growing our facility, expanding our staff, and welcoming new people ready to make EV history.”

To view the full press release, visit https://ibn.fm/jDuLL

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: to accelerate the commercial adoption of electric vehicles. By bringing together vehicles and charging technology with design, implementation, and financial services, the company provides solutions needed for the commercial world to commit to an EV future. For more information about the company, please visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Freight Technologies Inc. (Fr8Tech), a company developing solutions to optimize and automate the supply chain process, believes that technology can help streamline operations, improve safety, and increase efficiency within the fleet-tracking industry
• This outlook has informed the innovation and overall improvement of its fleet management offering, guaranteed improved customer service, and reduced operational costs, and contributing to the company’s growth
• Fr8Tech’s management is optimistic that as more people get to know and appreciate fleet technology, the company will continue to experience a steady and sustained growth in demand for its offerings, ultimately defining it as the go-to brand and platform for B2B cross-border shipping in the USMCA region

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process, offering a platform for B2B cross-border shipping in the USMCA region, is constantly pushing for more accessibility and affordability of fleet tracking technology. As a firm believer that technology can significantly help streamline operations, improve safety, and increase efficiency within the fleet tracking industry, Fr8Tech is constantly innovating and improving its existing products and services. This move has helped it differentiate itself in an industry that commands over $385 billion in revenue between the U.S. and Mexico alone and $732 billion domestically in the U.S. (https://ibn.fm/VSqwc).

Fr8Tech’s robust and innovative fleet management offering integrates GPS tracking, telematics, and automated logging for improved safety, reduced operational costs, improved efficiency, and overall improved customer service. In addition, structuring the entire product has made Fr8Tech’s…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• D-Wave’s quantum and quantum-hybrid solutions are uniquely suited for solving today’s optimization problems
• The company’s offerings aim to deliver customer value across several industries including logistics and supply chain, financial services, manufacturing, and life sciences, to name a few
• Boston Consulting Group estimates the near-term TAM for quantum hardware, software and service providers to be $400 million to $1 billion in the next three to five years

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services focused on delivering customer value via practical quantum applications, was recently featured in an article by TBD Media on the Reuters website titled Quantum Computing Emerges as Key to Solving Complex Business Problems (https://ibn.fm/EFJ6j). The company was profiled as one of “50 Leaders of Change” for its work in fueling the adoption of commercial quantum computing solutions, as enterprises seek solutions that help maximize efficiencies, decrease costs, fuel innovation and increase revenue. D-Wave is the world’s first commercial quantum computing company, solving businesses’ most complex computational challenges, spanning areas that include logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fraud detection, and financial modeling.

D-Wave aims to deliver customer value through easy-to-use, practical quantum applications that can address a broad range of businesses’ optimization problems, today. The company delivers quantum hardware, software – including the Leap(TM) quantum cloud service, and…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward-Looking Statements

This article contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which statements are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Forward-looking statements in this article include, but are not limited to, statements regarding the TAM for quantum computing, the development of D-Wave’s gate model quantum computer and the future impact of D-Wave’s technologies. We cannot assure you that the forward-looking statements in this article will prove to be accurate. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including general economic conditions and other risks; customer acceptance of our products and services; and the uncertainties and factors set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the registration statement on Form S-1 filed by the Company with the SEC on February 13, 2023, as well as factors associated with companies, such as D-Wave, that are engaged in the business of quantum computing, including anticipated trends, growth rates, and challenges in those businesses and in the markets in which they operate; the outcome of any legal proceedings that may be instituted against us; risks related to the performance of our business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and or timing thereof; the performance of our products; the effects of competition on our business; the risk that we will need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; the risk that we may never achieve or sustain profitability; the risk that we are unable to secure or protect our intellectual property; volatility in the price of our securities; the risk that our securities will not maintain the listing on the NYSE; changes in applicable laws and regulations; the effect of pandemics, geopolitical events, natural disasters, wars, or terrorist acts on our business or the economy in general; and the impact of inflation. Furthermore, if the forward-looking statements contained in this article prove to be inaccurate, the inaccuracy may be material. In addition, you are cautioned that past performance may not be indicative of future results. In light of the significant uncertainties in these forward-looking statements, you should not place undue reliance on these statements in making an investment decision or regard these statements as a representation or warranty by any person we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this article represent our views as of the date of this article. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this article.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Roth MKM has chosen IBN (InvestorBrandNetwork), an innovative corporate communications firm and content distributor, to provide key real-time coverage for its upcoming 35th annual Roth Conference. The conference is slated for March 12–14, 2023, at the Ritz Carlton in Dana Point, California. As a media sponsor, IBN will cover the event through an array of extensive corporate communications solutions; these communications are designed to heighten the visibility and widen the recognition of the conference as well as those involved in the conference, such as institutional investors and presenting companies. IBN will distribute this information through a wide range of digital channels, including IBN’s InvestorWire, one of 50-plus brands that are part of the IBN organization. During the conference, specially selected companies will have an opportunity to engage in valuable one-on-one or small-group meetings with highly respected institutional investors; the conference will also feature fireside chats and thematic industry panels. “ROTH MKM has been at the forefront of transactions management, advisory services and research over the past three decades,” said IBN communications director Jonathan Keim in the press release. “We have worked with their event team for more than 12 years now and are excited to be supporting this year’s flagship conference. Our team is leveraging an extensive network of thousands of downstream publishers and strategically targeted social media channels to drive interest among millions of online investors.”

To view the full press release, visit https://ibn.fm/sAnj2  

About Roth MKM

ROTH MKM, a relationship-driven investment bank focused on serving growth companies and their investors, specializes in partnership building between c-suite executives of pathbreaking companies and seasoned investors across a variety of sectors. The investment bank’s network comprises many clients and partners who work at the cutting edge of high-growth industries, including business services, healthcare, oil & gas, metals & mining, technology, media, agTech and sustainability. For more information about this company, please visit www.Roth.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Advisors Mortgage Group, based in Ocean Township, New Jersey, today commented on the recent announcement from the Department of Housing and Urban Development (“HUD”), through the Federal Housing Administration (“FHA”), that it is reducing annual mortgage insurance premiums by 30 basis points on FHA-insured mortgages starting March 20, 2023. The reduction will benefit approximately 850,000 borrowers over the next year and save these families an average of $800 annually. “These steps by HUD and the FHA are going to help many more people achieve the dream of owning a home,” said Erika Whalen, Advisors’ underwriting manager. “We at Advisors are excited to see these changes take place and that we now get to be a part of the American dream of homeownership for even more first-time homebuyers.”

To view the full press release, visit https://ibn.fm/n8wvO

About Advisors Mortgage Group

With big dreams and even bigger determination, Advisors Mortgage Group was founded in October 1999 by a single loan officer in a 400-square-foot office in Shrewsbury, New Jersey. In the years since its formation, Advisors has grown to serve not only the greater New Jersey area but also a vast portion of the United States. With branch offices up and down the East Coast and its corporate office in Ocean Township, New Jersey, Advisors Mortgage has established itself as a pillar of excellence in the mortgage industry. Its immense experience is Advisors Mortgage Group’s greatest asset and is the foundation of the success of the company and every Advisors branch and loan officer. In 2005, Advisors Mortgage Group was designated by the Federal Housing Authority as a Full Eagle FHA Underwriter. As a Full Eagle, Advisors has been able to expand its loan volume by approving loans, which a majority of the competition could not dream of. Advisors Mortgage Group has built a platform for a seamless and stress-free mortgage process for all of its customers, and it has that same mission throughout all of its offices. Advisors Mortgage Group understands that success cannot be attained without teamwork and communication, two of its most important strengths. Those looking to finance a home or refinance an existing mortgage may contact Advisors Mortgage at 855-LOANS-USA or visit its website at https://advisorsmortgage.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Nextech AR Solutions (OTCQX: NEXCF) (CSE: NTAR) (FSE: EP2), an augmented reality (AR), artificial intelligence-powered  3D model supplier for Amazon and other major e-commerce retailers, is announcing a rebranding as the company enters the AI space; the rebrand is designed to better reflect the company’s current technology and business. The company’s rebranded portfolio now includes Nextech3D.ai, Arway.ai and Toggle3D.ai. Part of the rebrand includes adding three new full-time AI scientists to the team; the new personnel will focus on the company’s AI development and support Nextech AR’s ambitious AI growth plans for 2023. According to the announcement, over the  years Nextech has built tens of thousands of high-quality, fully textured, photo-realistic 3D assets, complete with hundreds of thousands of individual parts; the company’s first clean dataset of 70,000-plus 3D objects and more than 2.2 million synthetically rendered reference photos represents a small portion of all the parts and assets in its model library, but is already larger than the largest publicly available 3D dataset. “We have been able to create incredibly powerful artificial intelligence that really changes the game, between what we have been able to produce with a human versus what’s happening now with our generative AI-Powered 3D model factory,” said Nextech3D.ai CEO Evan Gappelberg in the press release. “We effectively have transitioned from a diversified augmented reality company and pioneering metaverse company to a leading AI-powered 3D modeling for e-commerce company. We believe that we have a competitive advantage in the $100 billion TAM 3D market and that anyone in our industry that doesn’t embrace the disruptive power of generative AI will find themselves at an enormous and insurmountable disadvantage from both a cost and innovation perspective.”

To view the full press release, visit https://ibn.fm/Jf9tL

About Nextech AR Solutions Corp.

Nextech AR Solutions is a diversified augmented reality, AI-powered technology company that leverages proprietary artificial intelligence to create 3D experiences for the metaverse. Its main businesses are creating 3D WebAR photorealistic models for the Prime Ecommerce Marketplace as well as many other online retailers. The company develops or acquires what it believes are disruptive technologies and, once commercialized, spins them out as standalone public companies issuing a stock dividend to shareholders while retaining a significant ownership stake in the public spinout. On Oct. 26, 2022, Nextech AR spun out its spatial computing platform, ARway, as a standalone public company. Nextech AR retained a control ownership in ARway Corp. with 13 million shares, or a 50% stake, and distributed 4 million shares to Nextech shareholders. ARway Corp. is disrupting the augmented reality wayfinding market with a no-code, no-beacon spatial computing platform enabled by visual marker tracking. For more information about Nextech, please visit www.NextechAR.com.    

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Amesite (NASDAQ: AMST) CEO Ann Marie Sastry has made multiple stock purchases in AMST, an artificial intelligence (“AI”) software company that offers leading eLearning opportunities. According to the Form 4 filed with the Securities and Exchange Commission (“SEC”), Sastry acquired 2,000 shares of common stock, each at $3, for the purchase price of $6,000. This is the third in a series of Sastry’s recent stock purchases. In February, she purchased 2,000 shares of common stock, each at $2.42, for a total purchase price of $4,800. In early March, she purchased an additional 2,000 shares at $3 per share. Sastry has also never sold any of her common stock shares for Amesite, which total more than 531,000 with the three most recent stock purchases. Insider buying can be viewed as a sign that those inside the company have confidence in its prospects and optimism about the future value and growth in the company’s share price.

For more information, visit https://ibn.fm/XzDrL

About Amesite Inc.

Amesite, an artificial intelligence-driven platform and course designer, provides online products in the United States. The company uses machine learning to offer a mass customized experience to learners. Its customers include businesses, universities and colleges, K-12 schools, and non-profit organizations. The company was incorporated in 2017 and is headquartered in Detroit, Michigan. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel (OTCQB: SDCH), a provider of cybersecurity, privacy and technology services for emerging and middle-market companies, today announced an engagement with Virgin Voyages. Following months of collaboration, Virgin Voyages is enhancing its data privacy efforts with the addition of a virtual chief privacy officer (“vCPO”) from SideChannel to augment Virgin Voyages’ team and current efforts. “I feel very proud that our team’s work earned the trust of the Virgin Voyages crew and persuaded them to work even more closely with us,” said Brian Haugli, CEO of SideChannel. “Some companies do not think of cybersecurity and privacy until an event forces them to. Virgin Voyages is propelled to preemptively protect their customers, staff and all their data. We think that’s something worth celebrating.”

To view the full press release, visit https://ibn.fm/I5ue2

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite-level information security officers possesses a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, will be showcasing its Alkaline8(R) product line at Expo West 2023; the event is slated for March 9–11, 2023, and will be held in Anaheim, California. Specifically, the company noted that it will be showcasing its 2-Liter Shaq Paq — the fastest-growing product in its portfolio; other products on display will include the ecofriendly 750 aluminum bottle and Alkaline88 Sport, which launched last year. “We are excited to be exhibiting again at Expo West and showcasing our latest products, including the 2-liter Shaq pack, the eco-friendly 750 Aluminum bottle, and our Alkaline88 Sport lineup,” said The Alkaline Water Company president and CEO Frank Chessman in the press release. “Alkaline88 is all natural, buffer free, and has a Deliciously Smooth(TM) taste, so it’s demonstrated significant performance in the natural food channel and amongst consumers looking for a ‘better-for-you’ beverage. Expo West is one of the largest natural product trade shows in the world, attracting thousands of attendees from around the globe. It’s always a great opportunity for us to reconnect with important customers, meet industry leaders, and to showcase Alkaline88’s strength to potential new buyers looking to add a great product with a proven track record of growing retail sales to their shelves.”

To view the full press release, visit https://ibn.fm/zqu0H

About The Alkaline Water Company

The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with ecofriendly aluminum packaging options. With its innovative, state-of-the-art, proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked Clean Beverage label. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for Alkaline88. To learn more about the company, please visit www.Alkaline88.com and www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1), the digital face of the plant-based community that operates a one-stop shop for plant-based products, today announced the addition of Affirm (“AFRM”), the payment network that empowers consumers and helps merchants drive growth. According to the announcement, eligible customers can now choose flexible and transparent ways to pay for the plant-based brands they love across all of PlantX’s websites. “Some plant-based products are viewed as expensive luxury items, so we wanted to find a way to make it easier for everyone to try,” said PlantX CEO Lorne Rapkin. “Integrating Affirm’s payment solutions across all of our websites supports our mission of making plant-based goods more accessible to people worldwide by providing customers with payment flexibility.”

To view the full press release, visit https://ibn.fm/3eu8E

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is a one-stop shop for plant-based products. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering delivery service for meals and indoor plants, the company currently has plans underway to expand its product lines to include a juice and coffee company. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. Its successful enterprise is being built and fortified on partnerships with the top nutritionists, chefs and brands. The company’s digital presence works to eliminate the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s investor website at https://Investor.PlantX.com.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Processa Pharmaceuticals (NASDAQ: PCSA), the developer of the next-generation chemotherapy drugs that will provide a better safety-efficacy profile than widely used FDA-approved counterparts, will be presenting at the 33rd annual Oppenheimer Healthcare Conference, held on March 14, 2023. According to the announcement, Processa Pharmaceuticals CEO and president Dr. David Young is scheduled for a virtual presentation, which will begin at 12 p.m. EST. The presentation will include an overview of the company’s progress on key programs and upcoming data milestones. A replay of Young’s presentation will be available on the company’s website following its conclusion. In addition, company officials will be available for one-on-one meetings.

To view the presentation, visit https://ibn.fm/z8FX3

To view the full press release, visit https://ibn.fm/7mSXK

About Processa Pharmaceuticals Inc.

Processa Pharmaceuticals has a mission to develop the next-generation chemotherapy drugs that will provide a better safety-efficacy profile than FDA-approved counterparts. These FDA-approved drugs are some of the most widely used chemotherapy drugs for treating various types of cancers. Processa Pharmaceuticals uses its regulatory science approach to develop these drugs in order to achieve high-value milestones effectively and efficiently. Processa’s three next-generation chemotherapy oncology treatment programs are: Next Generation Capecitabine (PCS6422 and Capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers), Next Generation Gemcitabine (PCS3117 to treat pancreatic, lung, ovarian, breast, and other cancers) and Next Generation Irinotecan (PCS11T to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com. 

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

AnPac Bio-Medical Science (NASDAQ: ANPC), a company with operations in the United States and China focused on early cancer screening and detection, received the first payment in late February 2023 from a Malaysian customer that had purchased AnPac Bio’s Model AP9080 cancer detection devices. The contract for these devices totaled $1.5 million. According to the announcement, the proprietary Model AP9080 features ANPC’s Cancer Differentiation Analysis Technology (“CDA”), a patented, novel multicancer testing technology. Company representatives called the order a “milestone” because it is the first major sales of AnPac Bio’s cancer detection device in the southeast Asia region, representing the company’s entry into the global cancer detection equipment market and confirming AnPac Bio’s novel technology, reputation, and capabilities. “We are very pleased with this major milestone accomplishment,” said AnPac Bio-Medical Science co-CEO Dr. Chris Yu in the press release. “It showed that in addition to China and U.S., our novel cancer detection technology is also being recognized in other parts of Asia, which has significant market size and needs for general population based cancer screening and risk assessment. Due to our technology’s unique advantages (multicancer, cost effective, ability to detect early, and high sensitivity and specificity), our patented cancer detection technology is highly suited for the region. We expect significant revenue and growth potential in the region. We will also work very hard to replicate this success.”

To view the full press release, visit https://ibn.fm/ewzRU

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of June 30, 2022. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer-screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. The company intends to enter the business-to-business e-commerce food business with the acquisition of Fresh2 Ecommerce Inc. For more information about the company, visit www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, will be represented at two investor events in March: the Emerging Growth Conference and the VirtualInvestorConferences.com—Life Sciences Investor Forum. InMed CEO Eric A. Adams will present at both conferences. His presentation at the Emerging Growth Conference, which is scheduled for March 9, 2023, will start at 12:30 p.m. ET and will include a corporate overview of the company as well as a question-and-answer session. Adams’ presentation for the Life Sciences Forum presentation is scheduled for March 9, 2023; it will start at 11 a.m. ET. That presentation will also include an overview of the company’s current position as well as time for questions and answers. In addition, members of the InMed management team will be available for virtual one-on-one meetings with institutional and individual investors from March 9–14.

To learn more about the Emerging Growth Conference, visit https://ibn.fm/0DURg

To learn more about the Life Sciences Investor Forum, visit https://ibn.fm/gq0ub

To view the full press release, visit https://ibn.fm/2MXzg

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a global leader in the research, development and manufacturing of rare cannabinoids, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. The company also has significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors. For more information, please visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• SideChannel’s Investor Day presentation highlighted the company’s offering as well as gave investors an inside look at what the employees working with the company say about being vCISOs
• SideChannel’s flagship offering is a subscription service that is committed to creating top-tier cybersecurity programs for SMBs to help organizations protect their data and assets
• The company’s holistic approach generates proven results through identification, protection, detection, response, and recovery services, delivered by vCISOs with a combined experience spanning 400-plus years
• The cybersecurity market size is expected to grow from an estimated $173.5 billion in 2022 to $266.2 billion by 2027

SideChannel (OTCQB: SDCH), a company simplifying cybersecurity for mid-market companies by matching them with highly experienced information security officers at a cost lower than building an in-house information security team or hiring a full-time chief information security officer (“CISO”), offers virtual CISOs (“vCISOs”) that possess a combined 400-plus years of experience in cybersecurity covering a wide range of industries. Three SideChannel vCISOs shared their stories during this year’s Investor Day presentation – talking about how working as a vCISO for SideChannel has been a great experience that has allowed them to cater to clients while also making time for their own families (https://ibn.fm/oF91u).

Matt Klein, Patrick Dubois, and Stephen Dye shared what working at SideChannel has meant to them – recounting what it was like working in an office setting before coming to SideChannel and the transition that becoming virtual with SideChannel has made in their lives. The consensus of all three employees…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

ROTH MKM (“Roth”) today announced that it will host its 35th Annual Conference on March 12-14, 2023, at The Ritz-Carlton, Laguna Niguel, located in Dana Point, California. The annual event offers companies an extraordinary platform for relationship building with both existing and prospective institutional investors. Following its recent acquisition of MKM Partners, ROTH MKM looks forward to introducing the conference setting to many new employees and their clients. “Our conferences have always been relationship-driven, enabling emerging growth companies from a broad range of industries to meet and interact with interested investors,” said ROTH MKM Executive Chairman Byron Roth. “I am sure that our new MKM network will help make the conference even more productive than in the past. We welcome them and I hope to meet as many new attendees as possible.”

To view the full press release, visit https://ibn.fm/Ec39V

About ROTH MKM

ROTH MKM is a relationship-driven investment bank focused on serving growth companies and their investors. Its full service platform provides capital raising, high impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory, and corporate access. Headquartered in Newport Beach, California, ROTH MKM is a privately held, employee-owned organization and maintains offices throughout the U.S. For more information, please visit www.roth.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is a leader in innovative and rare disease treatment solutions with a strong North American commercial platform and a portfolio of proven best-in-class products. Their current focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy. They continue to build a highly differentiated company with a growing portfolio of innovative and high-value orphan and rare disease products that will underpin their growth for the next decade.

Their current leading products are IXINITY(R), an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B (a hereditary bleeding disorder characterized by a deficiency of clotting factor IX in the blood, which is necessary to control bleeding); Rasuvo(R) and Metoject(R), a unique formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall(R), an innovative prescription allergy medication with a unique mode of action; and Gleolan(R) (aminolevulinic acid hydrochloride or ALA HCl), an FDA-approved, orphan drug designated optical imaging agent currently indicated in patients with glioma (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery.

They have also licensed treosulfan, part of a preparative regimen for allogeneic hematopoietic stem cell transplantation to be used in combination with fludarabine, for commercialization in the United States and Canada. Treosulfan was approved by Health Canada in June 2021 and is marketed in Canada as Trecondyv(TM). Treosulfan is currently the subject of a regulatory review process with the US Food and Drug Administration.

Their mission is to provide the best healthcare products to healthcare professionals and patients. They strive to deliver on this mission by acting on their core values: Quality, Innovation, Customer Service, and Collaboration.

For more information, visit company’s website at www.Medexus.com.

To schedule a one-on-one meeting, please contact your ROTH MKM representative.

To view IBN’s coverage of the conference, visit https://ibn.fm/Roth2023

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at 35th Annual Roth Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Getaround (NYSE: GETR), the world’s first connected carsharing marketplace, will be featured in InvestorBrandNetwork’s (IBN’s) coverage of the 35th Annual Roth Conference. The Roth Conference is scheduled for March 12-14, 2023 at the Ritz-Carlton Laguna Niguel in Dana Point, California.

Getaround founder and CEO, Sam Zaid, and CFO, Tom Alderman, will participate in a fireside chat on March 13, 2023 at 2pm EST and will conduct meetings with institutional investors on March 13, 2023.

Interested investors and other parties can find additional information relating to Getaround by visiting the company’s Investor Relations website at investor.getaround.com.

About Getaround

Offering a 100% digital experience, Getaround makes sharing cars and trucks simple through its proprietary cloud and in-car Connect(R) technology. The company’s mission is to empower people to carshare everywhere and shift away from car ownership through instant and convenient access to desirable, affordable, and safe cars from entrepreneurial hosts. Getaround’s on-demand technology enables a contactless experience — no waiting in line at a car rental facility, manually completing paperwork, or meeting anyone to collect or drop off car keys. Getaround aims to utilize its peer-to-peer marketplace to help solve some of the most pressing challenges facing the world today, including environmental sustainability and access to economic opportunity. Launched in 2011, Getaround is available today in more than 1,000 cities across the United States and Europe. For more information, visit the company’s website at www.Getaround.com.

PR Contact:

Shyna Deepak

[email protected]

To schedule a one-on-one meeting, please contact your ROTH MKM representative.

To view IBN’s coverage of the conference, visit https://ibn.fm/Roth2023

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at 35th Annual Roth Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Sigma Additive Solutions (NASDAQ: SASI), a leading provider of quality assurance software to the commercial 3D printing industry, today announced that it will partner with DyeMansion, the global leader in connected and integrated post-processing solutions for industrial polymer 3D-printing. Under the collaboration, Sigma will add an integrated hardware/software solution option that offers extra quality assurance for DyeMansion’s post-processing solutions: DM60, Powershot Performance and Powerfuse S. “We’re thrilled to partner with DyeMansion and move Sigma’s powerful quality assurance beyond the borders of additive systems and into post processing,” said Sigma’s Chief Executive Officer Jacob Brunsberg. “I’m also very excited about the rollout of DyeMansion’s Workflow Center — it’s a fantastic addition to their product and will place vital data into the hands of owners and operators.”

To view the full press release, visit https://ibn.fm/nk7W9

About Sigma Additive Solutions Inc.

Sigma Additive Solutions is a leading provider of in-process quality assurance (“IPQA(TM)”) solutions to the additive manufacturing industry. Sigma specializes in the development and commercialization of real-time monitoring and analytics known as PrintRite3D(R) for 3D metal and polymer advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process, enabling significant cost-savings and production efficiencies by reducing waste, increasing yield and shortening cycle times. Sigma believes its software solutions will be a major catalyst for the acceleration and adoption of industrial 3D printing. For more information, please visit www.SigmaAdditive.com.

NOTE TO INVESTORS: The latest news and updates relating to SASI are available in the company’s newsroom at http://ibn.fm/SASI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

EverGen Infrastructure (TSX.V: EVGN) (OTCQX: EVGIF) is combating climate change and helping communities contribute to a sustainable future. Headquartered in Vancouver, British Columbia, EverGen is an established independent renewable energy producer which acquires, develops, builds, owns and operates a portfolio of Renewable Natural Gas, waste to energy, and related infrastructure projects in North America. For more information, visit the company’s website at www.EverGenInfra.com.

To schedule a one-on-one meeting, please contact your ROTH MKM representative.

To view IBN’s coverage of the conference, visit https://ibn.fm/Roth2023

About IBN’s Coverage

IBN, a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at 35th Annual Roth Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

FE Battery Metals (CSE: FE) (OTCQB: FEMFD), a publicly traded Canadian mineral exploration company, has entered into advertising agreements with several providers, including Future Money Trends LLC and Gold Standard Media LLC.  The announcement was made by FE Battery Metals CEO and director Gurminder Sangha, who explained that the agreements are for an initial term of one year, at an aggregate cost to the company of $500,000. “The providers will furnish the company with marketing, managing of campaigns, administrative services, creation of landing pages, native ads, email marketing and influencer endorsements,” said FE Battery Metals CEO and director Gurminder Sangha in the press release. “Certain functions of the providers may include ‘investor relations activities’ under the policies of the Canadian Securities Exchange and applicable securities laws. Each provider is an arm’s length party to the company.”

In addition, the company has also entered into an option agreement for the Senay Lithium Project (“SLP”), which is within an active lithium exploration area of northern Quebec. According to the announcement, the Senay Lithium Project is comprised of more than 3,100 hectares and is located adjacent to the Bourier project of Critical Elements Lithium Corporation (TSX-V: CRE). This newly acquired land package includes 59 mining claims within the northeast portion of the Northeast-Southwest striking 150 km long Lac des Montagnes volcano-sedimentary belt of Quebec; this area contains significant pegmatite showings and is one of the most active centers for lithium exploration in the province. With this new acquisition, FE Battery Metals now holds 4,795 hectares in the James Bay Area. “We are pleased to add the Senay Lithium Project to our lithium exploration portfolio,” said Sangha in the press release. “In addition, FE continues to advance its exploration efforts at the Augustus Lithium Project which is adjacent to the soon-to-be operational North American Lithium mine.”

To view the full press releases, visit https://ibn.fm/UnzOo and https://ibn.fm/xQWVf

About FE Battery Metals Corp.

FE Battery Metals is a Canadian mineral exploration company with a primary focus of acquiring mineral properties in the battery metal sector. The company’s goal is to identify, acquire and explore North American mineral prospects with a primary focus on lithium. The company’s strategy is to acquire and advance projects through prospecting and early-stage exploration; source joint venture partners to finance future exploration and project development; and create shareholder value through exploration success. For more information about the company, please visit www.FirstEnergyMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to FEMFF are available in the company’s newsroom at https://ibn.fm/FEMFF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Corporate Cronyism Hampers Growth and Innovation – Election of Three New Candidates to Board of Directors Proposed

Dissent and disagreement were revealed in a recent preliminary proxy statement from rare disease therapeutics company, Zevra Therapeutics, Inc. (formerly known as KemPharm, Inc.). In the preliminary proxy statement released February 27, 2023, the company announced that the Board nominated…

Read More>>

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Third-Party Content

The IW website may contain Third-Party Content articles and other content submitted by third parties, including articles submitted through the IW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of IW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and IW does not endorse, guarantee or make representations concerning the accuracy and completeness of any third-party content. You acknowledge that by IW providing you with this internet portal that makes accessible to you the ability to view third party content through the IW site, IW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. IW expressly disclaims liability relating to such third-party content. IW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, IW reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the Disclaimer at https://www.investorwire.com/disclaimer.

The disclaimers on the IW website are applicable to all content provided by IW, wherever published or re-published are at: https://www.investorwire.com/disclaimer

AnPac Bio (NASDAQ: ANPC) is a company with operations in the United States and China focused on early cancer screening and detection with plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian-sourced food products. The company today announced its entry into definitive investment agreements with certain accredited investors in a private placement transaction. Under the terms, the investors agreed to subscribe for and purchase, and the company agreed to issue and sell an aggregate of 16,666,665 newly issued Class A ordinary shares of the company, at a price of US$0.30 per ordinary share, or US$6.00 per ADS (1:20 ADS-to-share ratio), for an aggregate purchase price of US$5 million. Subject to customary conditions, the closing of the sale of the securities is expected to occur in late March. The company expects to use the proceeds for working capital and the expansion of its Asian food e-commerce business in the U.S.

To view the full press release, visit https://ibn.fm/QTd75

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of June 30, 2022. With two certified clinical laboratories in China and one CLIA and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer screening and detection tests, including CDA (Cancer Differentiation Analysis), bio-chemical, immunological, and genomics tests. The company intends to enter the business-to-business e-commerce food sector with the formation of its wholly owned subsidiary Fresh2 Technology Inc. and the acquisition of Fresh2 Ecommerce Inc. For more information, visit www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced the signing of a paid, joint proof-of-concept (“POC”) project with a leading global Japanese automaker. According to the update, the project consists of evaluating Foresight’s unique automatic calibration capabilities to ensure that the location and orientation of mono cameras on a vehicle is known at all times. The parties will collaborate to develop a breakthrough solution capable of detecting when a single camera’s position has changed as well as providing real-time correction of the camera’s position while the vehicle is in motion, through the use of Foresight’s proprietary software.

To view the full press release, visit https://ibn.fm/G8gGR

About Foresight Autonomous Holdings Ltd.

Foresight is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight’s vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Siyata Mobile (NASDAQ: SYTA, SYTAW), a global provider of innovative push-to-talk over cellular (“PoC”) and cellular signal booster solutions, today announced the successful deployment of its mission-critical push-to-talk (“MCPTT”) solution for security and other communications at the 2023 Special Olympics New York Winter Games. “For the second year in a row, our devices were donated to and used at the Special Olympics Winter Games in Syracuse, New York to equip certain security personnel and event volunteers with the communications tools they need to help keep athletes, coaches, volunteers and spectators safe,” said Marc Seelenfreund, Siyata CEO. “We are pleased to support this worthy cause and to be providing more solutions in support of the Games. Our SD7 MCPTT solution is well-suited for the severe weather conditions that can occur in Syracuse, the site for this year’s event.”

To view the full press release, visit https://ibn.fm/VziU1

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next-generation push-to-talk over cellular (“PoC”) solutions that include its devices and cellular booster systems. Its in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives. Its portfolio of enterprise grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signals in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible. Siyata’s common shares and previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. For more information about the company, visit www.SiyataMobile.com and UnidenCellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has announced uranium mineralization in drill hole CB-183-1 that expands the footprint of high-grade uranium mineralization at the Sakura Zone at the company’s Christie Lake Project. According to the announcement, UEC intersects additional high-grade uranium mineralization with CB-183-1 at the project; this intersection expands the footprint of the high-grade mineralization at the Sakura Zone, which was reported last year. According to the announcement, the project is in a premier location, just northeast of McArthur River, the world’s largest high-grade uranium mine, and along the same geological trend. The announcement noted that infrastructure advantage of the project, which straddles the Eastern Athabasca High Grade Uranium Corridor. The company noted that Christie Lake is one of the key projects in its Eastern Athabasca Hub strategy and offers excellent synergy potential with its Roughrider and Horseshoe-Raven projects. “The continued success at the Sakura Zone demonstrates the potential of the Yalowega Trend at Christie Lake to host high-grade uranium mineralization,” said Uranium Energy vice president of exploration, Canada, Chris Hamel in the press release. “We are eager to continue with exploration along this trend in the 2023 program. The Yalowega Trend is the northerly extension of the McArthur River fault system onto the Christie Lake Project and gives UEC the opportunity to explore along this uniquely well-endowed mineralized trend that only Cameco and Orano otherwise have access to.”

To view the full press release, visit https://ibn.fm/XfMin

About Uranium Energy Corp.

Uranium Energy Corp is the fastest-growing supplier of the fuel required for green-energy transition to a low-carbon future. UEC is the largest, diversified North American-focused uranium company, advancing the next generation of low-cost, environmentally friendly, in-situ recovery (“ISR”) mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub-and-spoke platforms in south Texas and Wyoming. These two production platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, UEC has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of North American-warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a Western Hemisphere pipeline of resource-stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles, through its subsidiary, Solectrac Electric Tractors, plans to join Farmers for Climate Action: Rally for Resilience. The grassroots alliance of farmers, farmworkers and farmer allies are participating in a rally this week held in Washington, DC. The purpose of the event is to ask policymakers to make climate change policy a priority in the 2023 Farm Bill. Led by the National Sustainable Agriculture Coalition and Farm Aid, and supported by an alliance of organizations, the three-day rally will be held March 6–8, 2023, in the nation’s capital; satellite events are also scheduled around the country. As part of the rally, a Solectrac electric tractor will be on display to show that the future of agriculture has arrived. “Electric tractors are an essential part of addressing the climate crisis and forging a sustainable future for farmers,” said Solectrac CEO Mani Iyer in the press release. “These tractors can be charged from renewable energy and not only eliminate on-site emissions but also provide a healthier work environment. . . . We want to urge Congress that electrification of agriculture is part of the myriad of solutions that we will need to pursue in order to attain a sustainable food system.”

In addition, the company announced that US Hybrid, also a subsidiary, is partnering with Mi-Jack to convert a rubber tire gantry (“RTG”) crane from fossil diesel to hydrogen powered. The “dream project” involves US Hybrid engineers coming up with a zero-emission way to power the large piece of machinery. The agreement calls for US Hybrid to manage procurement, engineering and design work related to the hydrogen propulsion project while Mi-Jack, an industry leader and innovator in rubber-tired gantry cranes, will install the hydrogen propulsion kit into the RTG crane at its Illinois facility; US Hybrid will also provide engineering diagrams and on-site support. “For our exceptional engineers at US Hybrid, this is a dream project,” said Ideanomics chief commercial officer Macy Neshati in the press release. “They get to come up with a zero-emission way to power a very big and energy intensive piece of machinery. . . . I want to extend a heartfelt thanks to Mi-Jack for taking action to decarbonize gantry cranes and trusting US Hybrid as their partner to do it.”

To view the full press releases, visit https://ibn.fm/Emx1M and https://ibn.fm/PNWmV

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: to accelerate the commercial adoption of electric vehicles. By bringing together vehicles, charging and financial solutions under one roof, the company is the one-stop partner needed to simplify the transition to, and operation of, any EV fleet. For more information about the company, please visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork